Explore the enduring challenges of treating HIV, its unique properties, and the progress made since the virus's discovery.

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

In this East African country, one of the poorest in the world, the elimination of US aid and the overall reduction in international funding have had an immediate impact on the fight against HIV and ...

In this article, ReiThera's scientific and operational leaders discuss ReiThera’s proprietary platforms, process development strategy and its evolving role as a CDMO partner in the advanced therapies ...

Detailed price information for Cocrystal Pharma Inc (COCP-Q) from The Globe and Mail including charting and trades.

Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that ...

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication process can cause alterations in genomic DNA, promoting cellular ageing, cancer, ...

Precision BioSciences, Inc. , a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today ...

Merck , known as MSD outside of the United States and Canada, today announced topline results from the pivotal double-blind Phase 3 trial of the investigational, once-daily, oral, two-drug, ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial. At week 24, the ...